Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,701.00
Bid: 1,854.00
Ask: 1,615.50
Change: 28.00 (1.67%)
Spread: -238.50 (-12.864%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,673.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: UK stocks advance as investors shrug off weak data

Thu, 21st Aug 2014 12:01

- Mining stocks fall as Chinese data weakens- Eurozone PMIs and UK retail sales disappoint- US data, Jackson Hole aheadtechMARK 2,810.76 +0.50%FTSE 100 6,772.04 +0.25%FTSE 250 15,797.15 +0.31%Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursday despite a barrage of weak economic data from across the globe."The data seen so far today hasn't been great but that hasn't affected investors' appetite for risk, as European indices have continued their march higher," said market analyst Craig Erlam from Alpari UK.London's Footsie was trading 0.25% higher at 6,772 by midday.Economic data misses forecastsMining stocks were under pressure in morning trade after manufacturing data from top metals consumer China disappointed, while metals prices weakened on the back of a stronger US dollar.The HSBC China manufacturing purchasing managers' index (PMI) dropped from 51.7 to a three-month low 50.3 in August. The fall ended a streak of four straight monthly improvements in activity growth and disappointed analysts looking for a slight dip to 51.5.The Eurozone composite PMI, which measures activity in both manufacturing and services, fell from 53.8 to 52.8 in August, missing the 53.4 forecast as readings from both sectors came in below expectations.Closer to home, UK retail sales growth came in at just 0.1% in July, under the 0.4% increase expected by analysts, according to Office for National Statistics. The ONS also released figures showing that while UK public finances improved last month borrowing still remains above the government's target.Looking ahead to the US session, stock futures on Wall Street were edging higher in pre-market trade ahead of a host of economic data, including jobless claims, the Markit manufacturing PMI, existing-home sales and the Philadelphia Fed index.Meanwhile, the Jackson Hole Symposium of central bankers is due to kick off later on with comments from policymakers around the world likely to be closely watched.Mining stocks fallWeak data from top metals consumer China and falling metal prices dampened the demand for mining stocks on Wednesday with Fresnillo, Randgold, Rio Tinto, Anglo American and BHP Billiton trading lower.BHP Billiton was still under pressure in the aftermath of Tuesday's underwhelming plans for a demerger. Chief financial officer Graham Kerr, who is due to be the head of the spin-off company, has been cited as saying that the lack of a share buyback - which many investors had been expecting - was a "sore point", while plans to give shareholders stock in the new firm could have "irritated" some who are not mandated to hold investments in Australia. Kazakh metal miner Kazakhmys hailed progress with a shake-up designed to focus it on the lucrative copper market, but shares fell sharply after it said 2014 gold production was likely to fall short of hopes.Oil and gas stocks were also out of favour including Ophir Energy, Tullow and Shell.Premier Oil was more or less flat after saying it had a "strong six months" with better-than-expected production leading to higher revenues and cash flows. However, it saw a sharp reduction in pre-tax profit in the first half due to impairments.Leading the upside in London were a raft of pharmaceutical and biotechnology stocks, including Astrazeneca, Glaxosmithkline, Shire and Hikma Pharmaceuticals.Financials such as Schroders, Aviva, Old Mutual and Hargreaves Lansdown were also providing a lift.FTSE 100 - RisersSchroders (SDR) 2,385.00p +2.36%AstraZeneca (AZN) 4,372.50p +2.04%GlaxoSmithKline (GSK) 1,438.00p +1.45%CRH (CRH) 1,391.00p +1.31%Ashtead Group (AHT) 945.50p +1.23%Old Mutual (OML) 196.20p +1.13%Barratt Developments (BDEV) 363.50p +1.08%Aviva (AV.) 521.00p +1.07%Diageo (DGE) 1,769.00p +1.00%Hargreaves Lansdown (HL.) 1,120.00p +0.99%FTSE 100 - FallersFresnillo (FRES) 938.50p -3.50%Kingfisher (KGF) 306.60p -1.73%Anglo American (AAL) 1,576.50p -1.10%Randgold Resources Ltd. (RRS) 4,947.00p -1.00%Royal Mail (RMG) 441.80p -0.88%Antofagasta (ANTO) 812.00p -0.85%Rio Tinto (RIO) 3,430.00p -0.81%Standard Chartered (STAN) 1,211.50p -0.78%Pearson (PSON) 1,120.00p -0.71%easyJet (EZJ) 1,330.00p -0.67%FTSE 250 - RisersRank Group (RNK) 166.00p +3.49%Imagination Technologies Group (IMG) 204.90p +3.48%Hikma Pharmaceuticals (HIK) 1,740.00p +2.84%Domino Printing Sciences (DNO) 647.00p +2.70%International Personal Finance (IPF) 519.00p +2.57%Amlin (AML) 439.00p +2.26%Fisher (James) & Sons (FSJ) 1,366.00p +2.25%Euromoney Institutional Investor (ERM) 1,073.00p +2.19%Senior (SNR) 287.70p +2.17%Xaar (XAR) 558.50p +2.10%FTSE 250 - FallersKazakhmys (KAZ) 292.90p -5.06%Thomas Cook Group (TCG) 119.80p -3.39%Just Retirement Group (JRG) 145.30p -3.20%Hochschild Mining (HOC) 162.20p -2.29%Centamin (DI) (CEY) 62.85p -2.26%Petra Diamonds Ltd.(DI) (PDL) 186.80p -2.05%Ophir Energy (OPHR) 225.20p -1.96%African Barrick Gold (ABG) 240.30p -1.52%Serco Group (SRP) 305.10p -1.39%Stock Spirits Group (STCK) 290.50p -1.36%BC
More News
Today 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
Today 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
Today 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
Today 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
Today 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
Today 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.